PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-177.89%
Negative net income growth while EQT stands at 1207.96%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
15.71%
Less D&A growth vs. EQT's 49.74%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
68.72%
Some yoy growth while EQT is negative at -13882.78%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-8.20%
Negative yoy SBC while EQT is 911.04%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-163.27%
Both reduce yoy usage, with EQT at -245.01%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-164.71%
Both yoy AR lines negative, with EQT at -327.92%. Martin Whitman would suspect an overall sector lean approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-78.79%
Both reduce yoy usage, with EQT at -161.12%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-3.45%
Both negative yoy, with EQT at -249.99%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
3.36%
Operating cash flow growth at 50-75% of EQT's 5.95%. Martin Whitman would worry about lagging operational liquidity vs. competitor.
-7.61%
Both yoy lines negative, with EQT at -63.77%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-96.47%
Both yoy lines negative, with EQT at -3615.12%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
7.61%
Purchases growth of 7.61% while EQT is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-214.29%
We reduce yoy sales while EQT is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-7.61%
We reduce yoy other investing while EQT is 81.96%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-406.71%
Both yoy lines negative, with EQT at -360.32%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.